# South Korea Drug Infusion System Market > South Korea Drug Infusion System Market Research Report: Size, Share, Trend Analysis By Product Type (Elastomeric Infusion System, Disposable Infusion System), By Applications (Oncology/Chemotherapy), By Mode of Administration (Intravenous), and By End-user (Hospitals) - Growth Outlook & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 7.47% - **2024:** $ 246.75 Million - **2025:** $ 265.18 Million - **2035:** $ 545 Million - **Key Players:** Baxter International (US), B. Braun Melsungen AG (DE), Medtronic (US), Smiths Medical (US), Fresenius Kabi (DE), Terumo Corporation (JP), ICU Medical (US), Halyard Health (US), Zyno Medical (US) **Report ID:** MRFR/MED/54294-HCR · **Pages:** 200 · **Author:** Rahul Gotadki · **Last Updated:** April 24, 2026 **URL:** https://www.marketresearchfuture.com/reports/south-korea-drug-infusion-system-market-56060 --- ## Market Summary ## **South Korea Drug Infusion System Market Overview** As per MRFR analysis, the South Korea Drug Infusion System Market Size was estimated at 216.25 (USD Million) in 2023.The South Korea Drug Infusion System Market is expected to grow from 340(USD Million) in 2024 to 700 (USD Million) by 2035. The South Korea Drug Infusion System Market CAGR (growth rate) is expected to be around 6.785% during the forecast period (2025 - 2035). **Key South Korea Drug Infusion System Market Trends Highlighted** The market for drug infusion systems in South Korea is expanding significantly due to a number of important factors. One of the primary causes driving demand for sophisticated drug infusion systems in South Korea is the country's aging population, as elderly people frequently need more regular medical care. Innovation and the use of cutting-edge technologies in clinics and hospitals are greatly aided by the South Korean government's initiatives to upgrade the country's medical facilities. This fosters an environment that is conducive to the development of drug infusion systems that are more effective and user-friendly. Technological developments, especially the incorporation of smart infusion pumps, are increasing the opportunities in the South Korean drug infusion system market. By providing improved safety features and accuracy, these systems help lower medication mistakes and boost patient outcomes. Devices that facilitate home healthcare management are also in greater demand as a result of the growing emphasis on patient-centric treatment. Given that patients choose medicines that can be given comfortably, this trend suggests that the market for portable and user-friendly infusion systems is expanding. The use of automated technologies and digital health solutions in drug infusion procedures has increased recently in the South Korean healthcare industry. In light of the COVID-19 pandemic, which has increased the significance of remote patient management, this is in line with the global trend of implementing digital health technologies. Furthermore, the South Korean Ministry of Food and Drug Safety's expanded regulatory support has expedited the licensing procedure for novel drug infusion technology, allowing new goods to reach the market more quickly. This confluence of elements creates a dynamic environment for the drug infusion system market in South Korea. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review **South Korea Drug Infusion System Market Drivers** **Rising Prevalence of Chronic Diseases** The South Korea Drug Infusion System Market is poised for growth due to the increasing prevalence of chronic diseases such as diabetes and cancer. According to the Korean National Health Insurance Service, the country reported over 3.2 million diabetes patients in 2020, a significant increase of about 18% over five years. Similarly, cancer patients have shown a rising trend, with a reported increase of 11% in the last decade. This growing patient population directly contributes to the demand for effective drug infusion systems, as healthcare providers increasingly require efficient methods for medication administration. Organizations such as the Korean Cancer Association play a crucial role in raising awareness and pushing for advancements in treatment technologies, thereby bolstering the South Korea Drug Infusion System Market. **Technological Advancements in Infusion Systems** Technological innovations have substantially transformed the South Korea Drug Infusion System Market, catalyzing growth and enhancing patient care. The adoption of smart infusion pumps equipped with features like dose error reduction systems is rising, directly improving patient safety and treatment efficacy. According to the Ministry of Food and Drug Safety, over 25% of medical institutions in South Korea transitioned to automated infusion systems in recent years. Companies such as Samsung Medison are at the forefront of developing embedded technology in medical devices, continually innovating to meet the growing demands of healthcare providers in South Korea. **Government Initiatives and Support** The South Korean government has made significant strides in enhancing healthcare infrastructure and technology, which has positively impacted the South Korea Drug Infusion System Market. Initiatives focused on healthcare technology innovation, particularly under the Digital Healthcare Initiative, aim to modernize existing healthcare frameworks and promote the use of advanced medical devices. The Health Insurance Review and Assessment Service reported a budget increase for investment in healthcare technology by 25% in the last two fiscal years. This financial backing, combined with support from organizations like the Korea Health Industry Development Institute, fosters an environment conducive to industry growth and innovation. **South Korea Drug Infusion System Market Segment Insights** **Drug Infusion System Market Product Type Insights** The South Korea Drug Infusion System Market is experiencing significant growth, particularly in various Product Types that cater to the healthcare industry. Among the key categories within this market are Elastomeric Infusion Systems and Disposable Infusion Systems, both of which are becoming increasingly important in clinical settings across South Korea. The Elastomeric Infusion System is recognized for its advantages, including the ability to provide a constant infusion rate and its portability, which is beneficial for outpatient treatments. This system is often used in pain management and chronic disease therapies, reflecting the growing demand for patient-centered care solutions in the country. On the other hand, Disposable Infusion Systems are gaining traction due to enhanced safety measures and reduced risk of infection, which is crucial in hospital environments. The ease of use and elimination of the need for sterilization of reusable equipment make them a preferred choice among healthcare providers. South Korea's healthcare sector is keenly focused on advancing patient safety and operational efficiency; thus, these Disposable Infusion Systems align well with these trends. The shifting landscape in healthcare practices, driven by technological advancements and increased attention to patient care, supports the ongoing development and adoption of these infusion systems. Moreover, regulatory frameworks in South Korea are evolving to accommodate innovative solutions in drug delivery, ensuring that both Elastomeric and Disposable Infusion Systems meet rigorous safety and efficacy standards. This regulatory support cultivates a conducive environment for market growth, while healthcare facilities increasingly invest in state-of-the-art infusion technology to optimize their treatment protocols. As a result, these Product Types will likely continue to play a crucial role in shaping the future of the South Korea Drug Infusion System Market, addressing the complex needs of the population and enhancing the overall quality of care. Overall, the emphasis on efficient, safe, and user-friendly drug delivery systems signifies a pivotal shift in healthcare practices within South Korea. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review **Drug Infusion System Market Application Insights** The Application segment of the South Korea Drug Infusion System Market showcases a crucial emphasis on areas like Oncology and Chemotherapy, reflecting the increasing prevalence of cancer in the nation. With South Korea experiencing a growing aging population and advances in healthcare technologies, the demand for sophisticated drug infusion systems is significant. This particular application is critical due to its role in delivering precise dosages of potent medications required for effective cancer treatment. The rise in cancer cases necessitates the availability of reliable drug infusion systems to enhance patient outcomes, emphasizing the importance of this application. Furthermore, the South Korea Drug Infusion System Market is seeing innovations aimed at improving the usability and efficiency of these systems in oncology settings, addressing the challenges healthcare professionals face in managing chemotherapy regimens. Enhanced delivery mechanisms and monitoring systems are likely to drive market growth, as they ensure patient safety and adherence to treatment protocols, making Oncology and Chemotherapy a dominant focus within this market segment. **Drug Infusion System Market Mode of Administration Insights** The South Korea Drug Infusion System Market has seen significant advancements in the Mode of Administration segment, particularly with intravenous (IV) therapy, which plays a crucial role in patient management across various healthcare settings. IV administration allows for the rapid delivery of medications, ensuring that patients receive timely and effective treatment, which is especially valuable in emergency and surgical situations. The increasing prevalence of chronic diseases and the aging population in South Korea underline the growing need for efficient drug delivery systems. Moreover, advancements in technology, such as smart infusion pumps and automated systems, enhance safety and reduce medication errors, thereby driving the adoption of intravenous methods. The rising focus on patient-centered care also emphasizes the importance of personalized IV therapy, tailoring treatments to individual patient needs. Furthermore, stringent regulations surrounding drug administration in South Korea necessitate high-quality systems for delivery, underlining the significance of intravenous methods in medical practices. Overall, the intravenous segment stands out as a dominant force within the South Korea Drug Infusion System Market, showcasing its pivotal role in enhancing patient outcomes. **Drug Infusion System Market****End-use****r Insights** The South Korea Drug Infusion System Market, particularly the End-user segment, showcases a pronounced focus on Hospitals as a critical setting for drug delivery systems. Hospitals in South Korea play a vital role in the healthcare infrastructure, equipped with advanced technology and specialized personnel to manage various medical treatments, catering to the diverse needs of patients. The rising prevalence of chronic diseases and the demand for efficient patient care have led to an increased reliance on sophisticated drug infusion systems within these institutions. Hospitals often dominate the usage of infusion systems, necessitating precision in medication administration and enhancing patient safety. Additionally, the growing trend towards minimally invasive procedures and the integration of smart infusion technology have further strengthened the position of hospitals within this market segment. The South Korea Drug Infusion System Market continues to evolve, driven by advancements in technology and the increasing emphasis on patient-centered care, making hospitals a significant focus for innovation in drug delivery systems. As healthcare regulations in South Korea enhance the quality of care, hospitals remain at the forefront of implementing these advanced solutions, reflecting a dynamic shift in the approach to treatment and patient management. **South Korea Drug Infusion System Market Key Players and Competitive Insights** The South Korea Drug Infusion System Market is characterized by a dynamic landscape where innovation, patient-centric solutions, and strategic collaborations play pivotal roles in shaping the competitive environment. With a growing emphasis on effective and safe drug administration methods, various players in this market continuously strive to enhance their product offerings, focusing on the integration of technology with healthcare solutions. The evolving regulatory requirements and increasing demand for advanced healthcare facilities further contribute to the competitive nature of this market, pushing companies to invest in research and development to maintain their market positions. Furthermore, regional healthcare reforms and the rising prevalence of chronic diseases necessitate the use of sophisticated drug infusion systems, creating ample opportunities for companies to differentiate their products and services in the South Korean healthcare sector. NSP Pharma has established a noteworthy presence in the South Korea Drug Infusion System Market, demonstrating a commitment to innovation and quality that resonates well with healthcare providers. The company's strengths lie in its strong research and development capabilities, allowing it to introduce state-of-the-art infusion technologies that cater to the specific needs of the South Korean healthcare landscape. NSP Pharma’s focus on building strategic partnerships with local hospitals and clinics enhances its distribution channels, further solidifying its foothold in the market. Additionally, the company is recognized for its robust customer support services, which facilitate seamless integration of its infusion systems within healthcare facilities, thereby reflecting its dedication to improving patient care and operational efficiency in South Korea's healthcare system. Celltrion has positioned itself effectively within the South Korea Drug Infusion System Market, offering a range of innovative products and services tailored to enhance drug delivery methods. With a strong emphasis on biologics and biosimilars, Celltrion leverages its expertise in biopharmaceuticals to develop drug infusion systems that enable efficient treatment options for patients. The company's robust market presence is reinforced by strategic collaborations and partnerships, which have allowed it to expand its portfolio and gain a competitive edge. Moreover, Celltrion’s commitment to research and development drives continuous improvements in its product offerings, ensuring they meet the high standards demanded by the healthcare sector in South Korea. Through mergers and acquisitions, Celltrion has broadened its market reach, enabling it to capitalize on emerging trends and evolving healthcare needs, which ultimately strengthens its position in the South Korean Drug Infusion System Market. **Key Companies in the South Korea Drug Infusion System Market Include** - NSP Pharma - Celltrion - Baxter - Medtronic - Korea Vaccine - Hanmi Pharmaceutical - Fresenius Kabi - DongA ST - Yumin Pharmaceutical - Terumo Corporation - LG Chem - Boryung Pharmaceuticals - Daewoong Pharmaceutical - Johnson & Johnson - Samsung Medical Center **South Korea Drug Infusion System****Market****Developments** The South Korea Drug Infusion System Market has experienced significant developments, with companies like NSP Pharma, Celltrion, Baxter, Medtronic, and others playing pivotal roles. There has been notable growth in market valuations attributed to increased healthcare infrastructure investment, driven by the country’s aging population and rise in chronic diseases. In September 2023, Baxter announced an upgrade in its infusion systems portfolio, enhancing efficiency and patient safety, which is crucial in a growing competitive landscape. Meanwhile, mergers and acquisitions have been of interest, particularly in May 2023 when Hanmi Pharmaceutical acquired a stake in a smaller firm to expand its drug delivery capabilities. Additionally, Samsung Medical Center has partnered with Fresenius Kabi to innovate advanced infusion technologies, reflecting a trend towards collaboration in the healthcare sector. Over the last two years, the COVID-19 pandemic has spurred innovation within drug infusion systems as hospitals adapted to changing demands. Regulatory bodies continue to promote advancements with supportive policies, further enhancing the market's potential. As such, continuous growth and innovations are expected in the South Korea Drug Infusion System Market, with key players adapting to meet emerging healthcare needs. **South Korea Drug Infusion System Market Segmentation Insights** **Drug Infusion System Market Product Type****Outlook** - Elastomeric Infusion System - Disposable Infusion System **Drug Infusion System Market Application****Outlook** - Oncology/Chemotherapy **Drug Infusion System Market Mode of Administration****Outlook** - Intravenous **Drug Infusion System Market****End-use****r****Outlook** - Hospitals ## Market Drivers ### Increased Focus on Patient Safety Patient safety remains a paramount concern within the drug infusion-system market in South Korea. The rise in medication errors and adverse drug events has prompted healthcare providers to adopt more stringent safety protocols. As a result, infusion systems that incorporate safety features, such as dose error reduction systems and alarm functionalities, are gaining traction. Regulatory bodies are also emphasizing the need for enhanced safety measures, which is likely to drive the adoption of advanced infusion systems. In 2025, it is estimated that around 30% of healthcare facilities in South Korea will implement new safety protocols related to drug infusion systems. This focus on patient safety not only enhances treatment outcomes but also fosters trust in healthcare providers, thereby positively impacting the drug infusion-system market. ### Advancements in Infusion Technology Technological advancements are significantly influencing the drug infusion-system market in South Korea. Innovations such as smart infusion pumps, which offer enhanced precision and safety features, are becoming increasingly prevalent. These devices are equipped with advanced software that allows for real-time monitoring and data collection, thereby reducing the risk of medication errors. The infusion technology segment is expected to account for over 40% of the market share by 2026, reflecting the growing reliance on sophisticated devices in clinical settings. Furthermore, the integration of IoT capabilities into infusion systems is anticipated to facilitate better patient management and streamline workflows in healthcare facilities. As hospitals and clinics seek to improve operational efficiency, the demand for advanced infusion technologies is likely to surge, propelling growth in the drug infusion-system market. ### Rising Prevalence of Chronic Diseases The drug infusion-system market in South Korea is significantly impacted by the rising prevalence of chronic diseases. Conditions such as diabetes, cancer, and cardiovascular diseases are becoming increasingly common, necessitating effective management strategies that often involve infusion therapies. As of 2025, it is estimated that over 25% of the population is living with at least one chronic condition, leading to a higher demand for drug infusion systems. This trend is likely to drive innovation in infusion technologies, as healthcare providers seek to offer more effective and personalized treatment options. Furthermore, the increasing burden of chronic diseases is expected to prompt healthcare systems to invest in advanced infusion solutions, thereby fostering growth in the drug infusion-system market. ### Rising Demand for Home Healthcare Solutions The drug infusion-system market in South Korea is experiencing a notable increase in demand for home healthcare solutions. This trend is driven by an aging population and a growing preference for at-home treatments. As of 2025, approximately 15% of the population is aged 65 and older, leading to a higher incidence of chronic diseases that require continuous medication. Home infusion systems provide patients with the convenience of receiving treatment in their own environment, which is often associated with improved patient satisfaction and adherence to therapy. The market for home healthcare is projected to grow at a CAGR of 8% over the next five years, indicating a robust opportunity for drug infusion-system manufacturers to innovate and cater to this segment. This shift towards home-based care is likely to reshape the landscape of the drug infusion-system market in South Korea. ### Growing Investment in Healthcare Infrastructure The drug infusion-system market in South Korea is benefiting from increased investment in healthcare infrastructure. The government has allocated substantial funds to enhance healthcare facilities and expand access to advanced medical technologies. In 2025, healthcare expenditure is projected to reach approximately $200 billion, with a significant portion directed towards upgrading medical equipment, including drug infusion systems. This investment is expected to improve the quality of care and increase the availability of modern infusion technologies in hospitals and clinics. Additionally, the establishment of specialized infusion centers is likely to create new opportunities for market players. As healthcare infrastructure continues to evolve, the drug infusion-system market is poised for growth, driven by enhanced capabilities and improved patient care. ## Future Outlook The [Drug Infusion System Market](https://www.marketresearchfuture.com/reports/drug-infusion-system-market-6207) in South Korea is poised for growth at 7.47% CAGR from 2025 to 2035, driven by technological advancements and increasing healthcare demands. **New opportunities:** - Development of smart infusion pumps with IoT connectivity - Expansion of home healthcare infusion services - Integration of AI for personalized medication delivery By 2035, the market is expected to achieve substantial growth and innovation. ## Segment Insights ### By Product Type: Elastomeric infusion system (Largest) vs. Insulin pump (Fastest-Growing) In the South Korea drug infusion-system market, the distribution of market share among product types reveals that the elastomeric infusion system holds the largest share due to its versatility and cost-effectiveness. Conversely, insulin pumps, although currently smaller in market share, are gaining traction among healthcare providers and patients, indicating a shift toward personalized medicine and chronic disease management. Growth trends in this sector reflect increasing demand for advanced drug delivery systems, particularly in chronic disease treatment such as diabetes and pain management. The expansion of home healthcare services and rising awareness about the benefits of patient-controlled analgesia and insulin management are significant growth drivers. Technological advancements are also enhancing the performance and usability of these devices, further catalyzing market expansion. Elastomeric infusion system (Dominant) vs. Insulin pump (Emerging) The elastomeric infusion system stands as a dominant player in the South Korea drug infusion-system market, recognized for its robust design and ease of use, making it a preferred choice among healthcare providers for various therapeutic applications. It operates without the need for external power sources, providing flexibility and reliability in patient care. On the other hand, the insulin pump is emerging rapidly, driven by advancements in technology that facilitate better glucose control and personalized treatment regimens. Its ability to deliver precise insulin dosages and integrate with continuous glucose monitoring systems is making it increasingly vital for diabetic patients. This duality highlights the balance between established and innovative solutions in the sector. ### By Application: Oncology/Chemotherapy (Largest) vs. Diabetes (Fastest-Growing) The South Korea drug infusion-system market is characterized by significant segments including Oncology/Chemotherapy, Diabetes, Analgesia, Nutrition, Hematology, Pediatrics, and Others. Among these, Oncology/Chemotherapy holds the largest market share, driven by the rising incidence of cancer and an increasing focus on treatment options. Diabetes is identified as a rapidly growing segment, fueled by the rising prevalence of diabetes in the population and advancements in infusion technologies. Growth trends in the application segment reflect a notable shift towards more personalized treatment approaches, particularly in Oncology/Chemotherapy and Diabetes. Advanced drug infusion systems are being integrated into treatment regimens, enhancing patient outcomes and convenience. The growing elderly population and lifestyle changes are also major drivers for the expansion of these segments, leading to increased demand for efficient drug delivery systems in disease management. Oncology/Chemotherapy (Dominant) vs. Diabetes (Emerging) Oncology/Chemotherapy is positioned as the dominant force within the South Korea drug infusion-system market, largely due to an escalating focus on cancer care and innovative therapies. This segment benefits from substantial investments in research and growth of targeted therapies, commanding a significant market presence. Conversely, Diabetes is emerging rapidly, with its growth driven by alarming rates of diabetes diagnoses and an urgent need for effective management solutions. Infusion systems tailored for diabetes offer precise dosing and enhanced patient adherence, making them a vital part of modern treatment strategies. Both segments epitomize the evolving landscape of healthcare, wherein specialized infusion technologies play a crucial role in addressing the distinct needs of patients. ### By Mode of administration: Intravenous (Largest) vs. Subcutaneous (Fastest-Growing) In the South Korea drug infusion-system market, the mode of administration segment reflects distinct distribution patterns. The intravenous method holds the largest share, attributed to its efficiency in delivering medications directly into the bloodstream. Subcutaneous administration, while currently smaller, is gaining traction owing to its patients' increased preference for at-home treatments. Other methods like arterial and epidural are present but occupy niche positions within the overall market share. Growth trends indicate a substantial rise in demand for subcutaneous methods, propelled by advancements that enhance user convenience and comfort. The focus on outpatient care is also steering the market towards less invasive procedures. Both intravenous and subcutaneous methods are capitalizing on technological innovations to improve infusion systems, thus catering to a widening patient base. Intravenous (Dominant) vs. Subcutaneous (Emerging) Intravenous administration remains the dominant mode within the South Korea drug infusion-system market, praised for its rapid onset of action and suitability for a variety of therapeutic areas, including critical care. The method is often preferred in clinical settings due to its ability to deliver precise dosages effectively. Conversely, subcutaneous administration has emerged as a strong contender, particularly appealing to patients seeking autonomy over their treatment regimens. This technique allows self-administration, thus catering to the growing demand for home healthcare solutions. Both segments are essential in addressing diverse patient needs, leveraging technological advancements to optimize the overall treatment experience. ### By End-user: Hospitals (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing) In the South Korea drug infusion-system market, hospitals represent the largest share among end-user segments, leveraging the comprehensive infrastructure and demand for advanced medical treatments. This sector benefits from the growing number of patients requiring long-term therapies and surgical procedures, solidifying its position as the key player in the infusion systems market. Following hospitals, ambulatory surgical centers are emerging rapidly, driven by the increasing trend towards outpatient procedures and minimally invasive techniques, which enhance patient throughput and reduce healthcare costs. The growth trajectory for these segments is influenced by several factors, including technological advancements in drug delivery systems and rising public health awareness. Hospitals are expanding their service offerings with innovative infusion technologies, while ambulatory surgical centers are becoming more popular due to their efficiency and patient-centric care. Furthermore, the government's initiatives aimed at improving healthcare infrastructure present substantial opportunities for both segments, fostering a competitive landscape that is likely to evolve further in coming years. Hospitals (Dominant) vs. Ambulatory Surgical Centers (Emerging) Hospitals stand out as the dominant end-user segment in the drug infusion-system market, characterized by their extensive capabilities to handle complex treatments and a high volume of inpatient care. They typically utilize sophisticated infusion devices that ensure accurate dosing and monitoring, essential for managing critical patient therapies. Meanwhile, ambulatory surgical centers, recognized as the emerging segment, provide cost-effective and efficient treatment options, catering to a growing preference for outpatient services. These centers are increasingly adopting advanced infusion systems to enhance patient outcomes and minimize hospital stay durations. The competitive edge of ambulatory surgical centers lies in their ability to deliver quality care while reducing operational costs, making them a vital component of the healthcare delivery system. ## Competitive Benchmarking The drug infusion-system market in South Korea is characterized by a competitive landscape that is both dynamic and multifaceted. Key growth drivers include the increasing prevalence of chronic diseases, advancements in technology, and a growing emphasis on patient safety and comfort. Major players such as Baxter International (US), B. Braun Melsungen AG (DE), and Medtronic (US) are strategically positioned to leverage these trends. Baxter International (US) focuses on innovation in infusion technology, while B. Braun Melsungen AG (DE) emphasizes regional expansion and partnerships to enhance its market presence. Medtronic (US) is actively pursuing digital transformation initiatives, which collectively shape a competitive environment that is increasingly reliant on technological advancements and strategic collaborations. In terms of business tactics, companies are localizing manufacturing and optimizing supply chains to enhance efficiency and responsiveness to market demands. The market structure appears moderately fragmented, with several key players exerting influence over various segments. This fragmentation allows for a diverse range of products and services, fostering competition that drives innovation and quality improvements across the sector. In October 2025, Baxter International (US) announced the launch of a new infusion pump designed to improve medication delivery accuracy. This strategic move is significant as it aligns with the growing demand for precision in drug administration, potentially enhancing patient outcomes and solidifying Baxter's position as a leader in infusion technology. The introduction of this product may also serve to differentiate Baxter in a competitive market where technological innovation is paramount. In September 2025, B. Braun Melsungen AG (DE) expanded its manufacturing capabilities in South Korea through a new facility aimed at increasing production efficiency. This expansion is likely to bolster the company's supply chain resilience and reduce lead times, thereby enhancing its competitive edge. Such investments in local manufacturing reflect a broader trend among companies to adapt to regional market needs and improve operational agility. In August 2025, Medtronic (US) entered into a strategic partnership with a local healthcare provider to integrate AI-driven analytics into its infusion systems. This collaboration is indicative of a growing trend towards digitalization in the healthcare sector, where data-driven insights can enhance clinical decision-making and improve patient care. By leveraging AI, Medtronic may position itself at the forefront of innovation in drug infusion systems, potentially reshaping the competitive landscape. As of November 2025, current competitive trends in the drug infusion-system market include a pronounced focus on digitalization, sustainability, and the integration of AI technologies. Strategic alliances are increasingly shaping the landscape, enabling companies to pool resources and expertise to drive innovation. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition towards a model that prioritizes technological innovation, supply chain reliability, and enhanced patient outcomes. This shift underscores the importance of adaptability and forward-thinking strategies in a rapidly changing market. ## Recent News & Developments The South Korea Drug Infusion System Market has experienced significant developments, with companies like NSP Pharma, Celltrion, Baxter, Medtronic, and others playing pivotal roles. There has been notable growth in market valuations attributed to increased healthcare infrastructure investment, driven by the country’s aging population and rise in chronic diseases. In September 2023, Baxter announced an upgrade in its infusion systems portfolio, enhancing efficiency and patient safety, which is crucial in a growing competitive landscape. Meanwhile, mergers and acquisitions have been of interest, particularly in May 2023 when Hanmi Pharmaceutical acquired a stake in a smaller firm to expand its drug delivery capabilities. Additionally, Samsung Medical Center has partnered with Fresenius Kabi to innovate advanced infusion technologies, reflecting a trend towards collaboration in the healthcare sector. Over the last two years, the COVID-19 pandemic has spurred innovation within drug infusion systems as hospitals adapted to changing demands. Regulatory bodies continue to promote advancements with supportive policies, further enhancing the market's potential. As such, continuous growth and innovations are expected in the South Korea Drug Infusion System Market, with key players adapting to meet emerging healthcare needs. ## Report Scope | MARKET SIZE 2024 | 246.75(USD Million) | | --- | --- | | MARKET SIZE 2025 | 265.18(USD Million) | | MARKET SIZE 2035 | 545.0(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 7.47% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Baxter International (US), B. Braun Melsungen AG (DE), Medtronic (US), Smiths Medical (US), Fresenius Kabi (DE), Terumo Corporation (JP), ICU Medical (US), Halyard Health (US), Zyno Medical (US) | | Segments Covered | Product Type, Application, Mode of administration, End-user | | Key Market Opportunities | Integration of smart technology in drug infusion systems enhances patient safety and operational efficiency. | | Key Market Dynamics | Rising demand for advanced drug infusion systems driven by regulatory changes and technological innovations in South Korea. | | Countries Covered | South Korea | ## Frequently Asked Questions **Q: What is the current valuation of the drug infusion-system market in South Korea?** A: The market valuation was $246.75 Million in 2024. **Q: What is the projected market size for the drug infusion-system market by 2035?** A: The market is expected to reach $545.0 Million by 2035. **Q: What is the expected CAGR for the South Korea drug infusion-system market during the forecast period 2025 - 2035?** A: The expected CAGR is 7.47% during the forecast period. **Q: Which product type segment had the highest valuation in 2024?** A: The disposable infusion system segment had a valuation of $90.0 Million in 2024. **Q: What are the key applications driving the drug infusion-system market in South Korea?** A: Key applications include oncology/chemotherapy, diabetes, and analgesia, with valuations of $90.0 Million, $70.0 Million, and $60.0 Million respectively in 2024. **Q: Which mode of administration is most prevalent in the drug infusion-system market?** A: Intravenous administration is the most prevalent, with a valuation of $230.0 Million in 2024. **Q: What end-user segment contributed the most to the market in 2024?** A: Hospitals contributed the most, with a valuation of $270.0 Million in 2024. **Q: Who are the key players in the South Korea drug infusion-system market?** A: Key players include Baxter International, B. Braun Melsungen AG, Medtronic, and Fresenius Kabi. **Q: What is the valuation range for the elastomeric infusion system segment?** A: The elastomeric infusion system segment had a valuation range of $30.0 Million to $70.0 Million in 2024. **Q: How does the projected growth of the drug infusion-system market compare to its 2024 valuation?** A: The market is projected to grow from $246.75 Million in 2024 to $545.0 Million by 2035, indicating substantial growth. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/south-korea-drug-infusion-system-market-56060*